Close Menu

Recombinant DNA and/or Biological Materials (IBC)

The Institutional Biosafety Committee (IBC) includes oversight of experimentation that involves recombinant DNA, biological materials (e.g., infectious agents), and other potentially hazardous agents (e.g., carcinogens). Please submit an email to if you have any questions or would like to submit an application for review.

IBC Application
IBC Annual Progress Report

More Information About Biosafety and Federal Requirements

NIH Office of Biotechnology Activities and Guidelines


IBC Chair

Todd Diel

Executive Officer – IBC Office